Research Articles | Page 18 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Myelodysplastic Syndromes: A Review of Therapeutic Progress Over the Past 10 Years Jun 2020 Expert Review of Anticancer Therapy Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management Jun 2023 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management Aug 2020 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management Nov 2020 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management" Jan 2021 American Journal of Hematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management" Mar 2021 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes with ring sideroblasts Oct 2023 Hematological Oncology Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version Oct 2024 PDQ Cancer Information Summaries Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version Mar 2019 National Cancer Institute Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes Treatment (PDQ®): Health Professional Version Sep 2024 PDQ Cancer Information Summaries Myelodysplastic Syndromes (MDS)